Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Noe

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|July 12, 2008
Short-term response to adalimumab in childhood inflammatory bowel diseaseJoshua D Noe, Marian Pfefferkorn
Pediatric Annals|May 30, 2009
Navigating recurrent abdominal pain through clinical clues, red flags, and initial testingJoshua D Noe, B U K Li
Pediatric Research|August 5, 2011
Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric Crohn diseaseSteven J Steiner, Joshua D Noe, Scott C Denne
JPGN Reports|May 11, 2026
Leukocytoclastic vasculitis and necrobiotic pulmonary nodules in endoscopic remission of ulcerative colitisJoshua D Noe, James Bistolarides, Karolyn A Wanat, et al.
Clinical Pharmacology and Therapeutics|November 5, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical Pharmacokinetics|August 30, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Therapeutic Drug Monitoring|June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World DataKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Inflammatory Bowel Diseases|January 13, 2016
Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBDJennifer G Walter, Stacy A Kahn, Joshua D Noe, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|July 12, 2008
Short-term response to adalimumab in childhood inflammatory bowel diseaseJoshua D Noe, Marian Pfefferkorn
Pediatric Annals|May 30, 2009
Navigating recurrent abdominal pain through clinical clues, red flags, and initial testingJoshua D Noe, B U K Li
Pediatric Research|August 5, 2011
Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric Crohn diseaseSteven J Steiner, Joshua D Noe, Scott C Denne
JPGN Reports|May 11, 2026
Leukocytoclastic vasculitis and necrobiotic pulmonary nodules in endoscopic remission of ulcerative colitisJoshua D Noe, James Bistolarides, Karolyn A Wanat, et al.
Clinical Pharmacology and Therapeutics|November 5, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical Pharmacokinetics|August 30, 2025
Hybrid Population Pharmacokinetic-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Therapeutic Drug Monitoring|June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World DataKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Inflammatory Bowel Diseases|January 13, 2016
Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBDJennifer G Walter, Stacy A Kahn, Joshua D Noe, et al.
Pageof 4